Vocimagene amiretrorepvec (Toca 511) for prodrug activator gene therapy in ovarian cancer models
Collins, S.A, Inagaki, A, Grosso, J, Matsuura, S, Kamath, P.N, Xu, X, Ince, T.A, Slomovitz, B, Kasahara, N
Published in Gynecologic oncology (01.06.2017)
Published in Gynecologic oncology (01.06.2017)
Get full text
Journal Article
Pseudotyped retroviral replicating vectors for combination prodrug activator gene therapy of ovarian cancer
Grosso, J, Inagaki, A, Collins, S.A, Matsuura, S, Kamath, P.N, Ince, T.A, Kasahara, N, Slomovitz, B
Published in Gynecologic oncology (01.06.2017)
Published in Gynecologic oncology (01.06.2017)
Get full text
Journal Article
Bridging the disparities gap: Implementation of a clinical practice guideline
Gonzalez, V., Lara, O.D., Kamath, P.N., Aguilar, V.D.C.
Published in Gynecologic oncology (01.06.2019)
Published in Gynecologic oncology (01.06.2019)
Get full text
Journal Article
Is there a role for for minnelide in uterine serous cancers?
de Haydu, C., Ramakrishnan, V., Kamath, P.N., Jordan, S., Hinshaw, H., Oleas, J.M., Slomovitz, B., Saluja, A., Ramakrishnan, S.
Published in Gynecologic oncology (01.07.2019)
Published in Gynecologic oncology (01.07.2019)
Get full text
Journal Article
Shifts in Practice Patterns: Addressing Disparities in Ovarian Cancer Care
Kamath, P.N., Schlumbrecht, M.P., George, S.H., Morales, G.J., Pearson, J.M., Slomovitz, B.M., Huang, M.
Published in Gynecologic oncology (01.10.2017)
Published in Gynecologic oncology (01.10.2017)
Get full text
Journal Article
Identifying disparities in germline and somatic testing in patients with ovarian cancer in a university health system
Kamath, P.N., Schlumbrecht, M.P., George, S., Slomovitz, B.M., Koru-Sengul, T., Miao, F., Driscoll, D., Oldak, S., Huang, M.
Published in Gynecologic oncology (01.06.2018)
Published in Gynecologic oncology (01.06.2018)
Get full text
Journal Article